Betaxolol 1 mg/mL oral suspension
Ingredients
| Ingredient | Role | For 100 mL |
|---|---|---|
| Betaxolol hydrochloride | active | 100 mg |
| SyrSpend SF pH 4 | vehicle | q.s. to 100 mL |
- Strength
- 1 mg/mL
- Starting material
- Betaxolol hydrochloride 20 mg tablets
- Container
- See the study
Amounts are ClinDose's arithmetic from the study's concentration; follow the study for the method.
Storage and beyond-use date
| Storage | BUD | Basis |
|---|---|---|
| Refrigerated | 60 days | Cited stability study. Duration supported by the cited stability study for this formula, container, and storage. |
| Room temperature | 15 days | Cited stability study. Duration supported by the cited stability study for this formula, container, and storage. |
Only the storage conditions the source covers are listed. Use the BUD assistant for other cases. The BUD may not be later than any component's expiration date. Verify against the current official USP chapter.
Ingredient checks
No FDA compounding list or NIOSH flags for the active ingredient.
Source
Dubois L, Bouguergour C, Paoli-Lombardo R, et al.. Compounding and stability studies of liquid oral formulations of beta-blockers (bisoprolol, betaxolol, and nadolol) for paediatric patients. J Pharm Pharm Sci. 2025;28:15387. PMID 41409535. PMC12705468. License: CC BY (checked 2026-11-06). Read the article · DOI
For licensed clinicians. Use with clinical judgment.